This study is accepting new patients by invitation only
A Study of Experimental Inhaled Treprostinil For Pulmonary Hypertension due to Parenchymal Lung Disease (scarred lung tissue)
a study on High Blood Pressure Interstitial Lung Disease Fibrosis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Davis UCSD UCSF
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- United Therapeutics
- ID
- NCT02633293
- Phase
- Phase 2/3
- Study Type
- Interventional
- Last Updated